PROCEPT BioRobotics (PRCT) Revenue (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Revenue data on file, last reported at $83.1 million in Q1 2026.

• Revenue for Q1 2026 came in at $83.1 million, up 20.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $322.0 million (up 29.26% YoY), and the FY2025 annual result was $308.1 million, up 37.22% from the prior year.
• Revenue advanced to $83.1 million in Q1 2026 per PRCT's latest filing, from $76.4 million in the prior quarter.
• Over five years, Revenue peaked at $83.3 million in Q3 2025 and troughed at $14.2 million in Q1 2022.
• A 5-year average of $48.6 million and a median of $44.5 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue soared 134.76% in 2022, then rose 11.94% in 2025.
• A 5-year view of Revenue shows it stood at $23.8 million in 2022, then surged by 83.29% to $43.6 million in 2023, then jumped by 56.57% to $68.2 million in 2024, then climbed by 11.94% to $76.4 million in 2025, then increased by 8.84% to $83.1 million in 2026.
• Business Quant data shows PRCT's Revenue at $83.1 million in Q1 2026, $76.4 million in Q4 2025, and $83.3 million in Q3 2025.